MARATTO

article · Afro-Egyptian Journal of Infectious and Endemic Diseases

Endothelail and Stress Index as One of New Prognostic Determinants of COVID- 19 Severity

20231 citationOpen accessPharos University in Alexandria

Abstract

Background and study aim: COVID-19 pandemic began in China in 2019. The disease course can be unnoticed, mild, aggressive or end by death. Several prognostic markers have been studied in order to minimize the severity of the disease or its danger. This study aims at investigating the prognostic value of Endothelial activation and stress index (EASIX) as a new predictor in addition to some haematological, biochemical, computerized tomography (CT), electrocardiogram (ECG) and echocardiography (Echo) findings as determinants of the COVID-19 severity. Patients and Methods: ‎‎‎ 105 non-vaccinated COVID-19 patients aged 17–89 admitted to a referral hospital in Alexandria, Egypt, from January to August 2022 with positive nasopharyngeal qualitative PCR swabs were included. Considerations include demographics, history, hospital stay, and intensive care unit (ICU) admission. Complete blood picture with differential count, C-reactive protein, ferritin, D-Dimer, liver and renal function tests, lactate dehydrogenase, cardiac markers, EASIX, chest CT, ECG, and Echo were done‎.‎ Results: EASIX along with D-Dimer and ferritin showed statistically significant sensitivity and specificity when analysed as predictors for COVID-19 mortality, need for ICU admission and mechanical ventilation, while lymphocyte/monocyte ratio (LMR) showed statistically significant sensitivity and specificity only for COVID-19 mortality and need for ICU admission. D-Dimer had the highest overall accuracy, followed by ferritin, EASIX, and the lowest accuracy appear in LMR‎. Conclusion and recommendation: Because of its strong correlation with COVID-19 mortality, ESAIX should be added as a new biomarker to the existing set of biomarkers linked to poor prognosis namely D-Dimer and ferritin ‎‎.

Research topics

  • Cardiovascular Disease and Adiposity
  • Biomarkers in Disease Mechanisms

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/aeji.2023.206428.1287

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.